Hester Biosciences announced a substantial rise in standalone net profit for the quarter ended September 2016. During the quarter, the profit of the company rose 38.91% to Rs 59.69 million from Rs 42.97 million in the same quarter previous year.
Revenues for the quarter rose 23.43% to Rs 296.30 million, compared with Rs 240 million for the prior year period.
Operating margin for the quarter stood at 31.03 percent as compared to 31.03 percent for the previous year period. Operating Income for the quarter was Rs 91.94 million, compared with Rs 74.48 million in the previous year period.
Earnings per share for the quarter stood at Rs 7.02, registering 39.01% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Sep - 16 | Sep - 15 | %Change |
| Revenues | 296.30 | 240.05 | 23.43 |
| Net Profit | 59.69 | 42.97 | 38.91 |
| Diluted EPS | 7.02 | 5.05 | 39.01 |
Shares of the company declined Rs 24.55, or 3.2%, to settle at Rs 742.60. The total volume of shares traded was 21,878 at the BSE (Thursday).
